Affiliated with a Castle Connolly Top Hospital
Who is Dr. Blayney, Medical Oncologist in Stanford, CA?
Dr. Douglas Blayney, MD is a Medical Oncologist, who primarily practices in Stanford, CA with 2 additional practice locations. He is board certified. Dr. Blayney completed his residency at Univ Ca San Diego Med Ctr, Internal Medicine. Dr. Blayney is fluent in English and Spanish, and is currently seeing new patients. Dr. Blayney’s practice accepts Medicaid, Medicare and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Blayney’s office.
What are Areas of Expertise for Dr. Blayney?
Dr. Douglas Blayney, MD is a highly-rated, board-certified Medical Oncologist known for expertly diagnosing, treating, and managing a wide array of related conditions and procedures. Utilizing the latest medical advancements and evidence-based practices, Dr. Blayney empowers patients to confidently navigate their health journey, specializing in Breast Cancer, Cancer Survivors-Late Effects of Therapy, and comprehensive wellness support. Serving the Stanford, CA community, Dr. Blayney is dedicated to enhancing lives through expert, patient-centered care.
Where did Dr. Blayney go to medical school and complete their residency?
Fellowship: Medicine Branch, National Cancer Institute, Bethesda, Maryland
Residency: Univ Ca San Diego Med Ctr, Internal Medicine | UCSD School of Medicine
Medical School: University of Ca, San Diego, Sch of Med, La Jolla Ca
Is Dr. Blayney board certified as a Medical Oncologist?
Yes, Dr. Douglas Blayney, MD is board certified by the American Board of Internal Medicine , American Board of Internal Medicine since 1983, American Board of Internal Medicine since 1980
What languages does Dr. Blayney speak?
Dr. Blayney and their clinical team can communicate with patients in the following languages:
English
Spanish
What conditions does a Medical Oncologist like Dr. Blayney typically treat?
As a Medical Oncologist, Dr. Blayney diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Blayney. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology.
Also known as:
- Breast Cancer
- Mammary cancer
- Breast carcinoma
- Breast tumor
ICD-10 Codes:
- C50912: Malignant neoplasm of unspecified site of left female breast
- C50911: Malignant neoplasm of unspecified site of right female breast
Also known as:
- Personal History of Breast Cancer
- Breast Cancer
- Past breast cancer
- Previous mammary malignancy
- History of breast tumor
ICD-10 Codes:
- Z853: Personal history of malignant neoplasm of breast
Also known as:
- Secondary Bone Cancer
- Bone Cancer
- Metastatic bone cancer
- Cancer spread to bone
- Bone metastases
ICD-10 Codes:
- C7951: Secondary malignant neoplasm of bone
What procedures does a Medical Oncologist like Dr. Blayney typically perform?
As a Medical Oncologist, procedures performed by Dr. Douglas Blayney may include:
- 3D Conformal Radiotherapy
- Adaptive Radiation Therapy (ART)
- Adrenalectomy
- Blood Thinning Therapy / Anticoagulation
- Blood Transfusion Consultation
- Blood Transfusion Follow Up
- Bone Excision
- Bone Grafting
Please contact Dr. Blayney's office directly to confirm care for your specific procedure, for more information, or to schedule a consultation.
Does Dr. Blayney accept my insurance?
Dr. Blayney accepts most major insurance plans. Important: Please call our office at before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Blayney accept in Stanford, CA?
Dr. Blayney in Stanford, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
All Other Third Party
CVS Health (formerly Aetna)
Medicaid
Medicare
UnitedHealth Group
View All Insurances
Where is Dr. Blayney's office located?
Recognitions
Publications
Transforming cancer care: are transdiscipliry approaches using design-thinking, engineering
, 2014
American society of clinical oncology 2013 top five list in oncology.
, 2013
ASCO's Quality Care Symposium (November 1-2, 2013) Abstracts
, 2013
Computerized prescriber order entry implementation in a physician assistant-maged hematology
, 2013
Measuring the Improving Quality of Outpatient Care in Medical Oncology Practices in the United
, 2013
Tumor Boards (Team Huddles) Aren't Enough to Reach the Goal
, 2013
Adoption of Gene Expression Profile Testing
, 2012
American Society of Clinical Oncology Identifies Five Key Opportunities to Improve Care
, 2012
Enhancing Quality Through Innovation
, 2010
Implementation of the Quality Oncology Practice Initiative at a University Comprehensive Cancer
, 2009
Myeloid Growth Factors
, 2013
Measuring and improving quality of care in an academic medical center.
, 2013
Comparative outcome of initial therapy for younger patients with mantle cell lymphoma
, 2012
The impact of obesity on receipt of adjuvant chemotherapy for breast cancer
, 2011
Commentary: six years of trends in oncology practice data.
, 2011
Myeloid Growth Factors
, 2011
Institutiol Variation in the Surgical Treatment of Breast Cancer A Study of the NCCN
, 2011
Continued Use of Trastuzumab Beyond Disease Progression in the tiol Comprehensive Cancer Network
, 2011
Challenges to tiol Cancer Institute-Supported Cooperative Group Clinical Trial Participation
, 2010
Partnering with payers for success
, 2009
Lymphoma After Solid Organ Transplantation: Risk, Response to Therapy
, 2009
Chemotherapy Use for Hormone Receptor-Positive, Lymph Node-Negative Breast Cancer
, 2008
The registry case finding engine
, 2007
Defining Quality: QOPI Is a Start.
, 2006
Dose-intense chemotherapy every 2 weeks with dose-intense cyclophosphamide, doxorubicin
, 2003
DECREASING RISK OF LEUKEMIA WITH PROLONGED FOLLOW
, 1987
THE HUMAN T-CELL LEUKEMIA-LYMPHOMA VIRUS IN THE SOUTHEASTERN UNITED-STATES
, 1983
THE HUMAN T-CELL LEUKEMIA LYMPHOMA VIRUS, LYMPHOMA, LYTIC BONE-LESIONS, AND HYPERCALCEMIA
, 1983
Transforming cancer care: are transdisciplinary approaches using design-thinking, engineering
, 2014
Breast cancer treatment across health care systems
, 2014
American society of clinical oncology 2013 top five list in oncology.
, 2013
ASCO's Quality Care Symposium (November 1-2, 2013) Abstracts
, 2013
Computerized prescriber order entry implementation in a physician assistant-managed hematology
, 2013
Measuring the Improving Quality of Outpatient Care in Medical Oncology Practices in the United
, 2013
Tumor Boards (Team Huddles) Aren't Enough to Reach the Goal
, 2013
Adoption of Gene Expression Profile Testing
, 2012
American Society of Clinical Oncology Identifies Five Key Opportunities to Improve Care
, 2012
Michigan Oncology Practices Showed Varying Adherence Rates To Practice Guidelines
, 2012
Enhancing Quality Through Innovation
, 2010
Implementation of the Quality Oncology Practice Initiative at a University Comprehensive Cancer
, 2009
Breast Cancer Treatment Across Health Care Systems
, 2014
Myeloid Growth Factors
, 2013
Measuring and improving quality of care in an academic medical center.
, 2013
Time to diagnosis and breast cancer stage by race/ethnicity
, 2012
Clinicopathologic Features, Patterns of Recurrence
, 2012
The anemia impact measure (AIM)
, 2012
The Effect of Age on Delay in Diagnosis and Stage of Breast Cancer
, 2012
Comparative outcome of initial therapy for younger patients with mantle cell lymphoma
, 2012
The impact of obesity on receipt of adjuvant chemotherapy for breast cancer
, 2011
Commentary: six years of trends in oncology practice data.
, 2011
Myeloid Growth Factors
, 2011
Institutional Variation in the Surgical Treatment of Breast Cancer A Study of the NCCN
, 2011
Continued Use of Trastuzumab Beyond Disease Progression
, 2011
Expansion of cancer care and control in countries of low and middle income: a call to action
, 2010
Challenges to National Cancer Institute-Supported Cooperative Group Clinical Trial Participation
, 2010
Partnering with payers for success
, 2009
Lymphoma After Solid Organ Transplantation: Risk, Response to Therapy
, 2009
Chemotherapy Use for Hormone Receptor-Positive, Lymph Node-Negative Breast Cancer
, 2008
The registry case finding engine
, 2007
Defining Quality: QOPI Is a Start.
, 2006
Dose-intense chemotherapy every 2 weeks with dose-intense cyclophosphamide, doxorubicin
, 2003
DECREASING RISK OF LEUKEMIA WITH PROLONGED FOLLOW
, 1987
THE HUMAN T-CELL LEUKEMIA-LYMPHOMA VIRUS IN THE SOUTHEASTERN UNITED-STATES
, 1983
THE HUMAN T-CELL LEUKEMIA LYMPHOMA VIRUS, LYMPHOMA, LYTIC BONE-LESIONS, AND HYPERCALCEMIA
, 1983
THE HUMAN T-CELL LEUKEMIA LYMPHOMA VIRUS ASSOCIATED WITH AMERICAN ADULT T-CELL LEUKEMIA LYMPHOMA
, 1983
What is Dr. Blayney's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Blayney's National Provider Identifier (NPI) number is 1811073877.
What common questions do patients ask about Dr. Blayney?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Blayney
What is Dr. Douglas Blayney's specialty?
Dr. Blayney is a Medical Oncologist near Stanford, CA.
What does a Medical Oncologist do?
An internist specializing in the diagnosis and treatment of various cancers and both benign and malignant tumors. This specialist determines and administers therapy for malignancies and collaborates with surgeons and radiation oncologists on additional cancer treatment options.
Is this Dr. Douglas Blayney affiliated with a ranked Castle Connolly Top Hospital?
Yes, Dr. Blayney is affiliated with Stanford Health Care - Stanford Hospital which is a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals
When to see a Medical Oncologist?: Guides for symptoms, conditions, and treatments
Understand your symptoms and know when it’s time to see a Medical Oncologist. Explore insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.
Is Douglas Blayney accepting new patients in Stanford, CA?
Yes, Dr. Douglas Blayney is accepting new patients at this time.
Does Dr. Douglas Blayney offer online booking?
Please contact Dr. Blayney's office for information about online booking, telehealth, or to schedule an appointment.
How can I make an appointment with Douglas Blayney?
Please contact Dr. Blayney's office for information regarding telehealth appointment availability or for scheduling assistance.
Which board certifications does Dr. Douglas Blayney have?
Dr. Douglas Blayney is certified by the American Board of Internal Medicine.
Other Medical Oncologist Near Stanford, CA
Medical Oncologist
Accepting patientsMedical Oncologist
Accepting patients
Medical Oncologist
Accepting patients